{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:33:58Z","timestamp":1778632438342,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,3,2]],"date-time":"2019-03-02T00:00:00Z","timestamp":1551484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s13730-019-00390-8","type":"journal-article","created":{"date-parts":[[2019,3,2]],"date-time":"2019-03-02T01:45:33Z","timestamp":1551491133000},"page":"188-193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["A case of biopsy-proven oxaliplatin-induced acute tubulointerstitial nephritis with thrombocytopenia and anemia"],"prefix":"10.1007","volume":"8","author":[{"given":"Shohei","family":"Yamada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3907-5347","authenticated-orcid":false,"given":"Masahiko","family":"Yazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichiro","family":"Koitabashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyunki","family":"Koike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yugo","family":"Shibagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,2]]},"reference":[{"key":"390_CR1","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1056\/NEJMoa032709","volume":"350","author":"T Andr\u00e9","year":"2004","unstructured":"Andr\u00e9 T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350:2343\u201351.","journal-title":"N Engl J Med"},{"key":"390_CR2","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1200\/JCO.1999.17.4.1141","volume":"17","author":"M Markman","year":"1999","unstructured":"Markman M, Kennedy A, Webster K, et al. Clinical features of hypersensitivity reactions to carboplatin. J Clin Oncol. 1999;17:1141\u20135.","journal-title":"J Clin Oncol"},{"key":"390_CR3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000178163","volume":"76","author":"A Polyzos","year":"2009","unstructured":"Polyzos A, Tsavaris N, Gogas H, et al. Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience. Oncology. 2009;76:36\u201341.","journal-title":"Oncology"},{"key":"390_CR4","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1093\/annonc\/mdf311","volume":"13","author":"G Pinotti","year":"2002","unstructured":"Pinotti G, Martinelli B. A case of acute tubular necrosis due to oxaliplatin. Ann Oncol. 2002;13:1951\u20132.","journal-title":"Ann Oncol"},{"key":"390_CR5","first-page":"254","volume":"2","author":"NT Phan","year":"2009","unstructured":"Phan NT, Heng AE, Lautrette A, et al. Oxaliplatin-induced acute renal failure presenting clinically as thrombotic micro-angiopathy: think of acute tubular necrosis. NDT Plus. 2009;2:254\u20136.","journal-title":"NDT Plus"},{"key":"390_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/ckj\/sft148","volume":"7","author":"N Filewod","year":"2014","unstructured":"Filewod N, Lipman ML. Severe acute tubular necrosis observed subsequent to oxaliplatin administration. Clin Kidney J. 2014;7:68\u201370.","journal-title":"Clin Kidney J"},{"key":"390_CR7","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1093\/ndt\/gfh826","volume":"20","author":"J Labaye","year":"2005","unstructured":"Labaye J, Sarret D, Duvic C, et al. Renal toxicity of oxaliplatin. Nephrol Dial Transplant. 2005;20:1275\u20136.","journal-title":"Nephrol Dial Transplant"},{"key":"390_CR8","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1177\/1060028014526160","volume":"48","author":"AY Joybari","year":"2014","unstructured":"Joybari AY, Sarbaz S, Azadeh S, et al. Oxaliplatin-induced renal tubular vacuolization. Ann Pharmacother. 2014;48:796\u2013800.","journal-title":"Ann Pharmacother"},{"key":"390_CR9","doi-asserted-by":"publisher","first-page":"918","DOI":"10.5812\/numonthly.8623","volume":"5","author":"F Ashrafi","year":"2014","unstructured":"Ashrafi F, Nematbakhsh M, Nasri H, Talebi A, Hosseini SM, Ashrafi M. Vacuolization, dilatation, hyaline cast, debris or degeneration: which one is the most correlated item to score the kidney damage pathologically in cisplatin induced nephrotoxicity model? Nephrourol Mon. 2014;5:918\u201320.","journal-title":"Nephrourol Mon"},{"key":"390_CR10","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1124\/jpet.106.110346","volume":"319","author":"A Yonezawa","year":"2006","unstructured":"Yonezawa A, Masuda S, Yokoo S. Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family). J Pharmacol Exp Ther. 2006;319:879\u201386.","journal-title":"J Pharmacol Exp Ther"},{"key":"390_CR11","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.bcp.2007.03.004","volume":"74","author":"S Yokoo","year":"2007","unstructured":"Yokoo S, Yonezawa A, Masuda S, et al. Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity. Biochem Pharmacol. 2007;74:477\u201387.","journal-title":"Biochem Pharmacol"},{"key":"390_CR12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.bcp.2010.11.016","volume":"81","author":"A Yonezawa","year":"2011","unstructured":"Yonezawa A, Inui KI. Organic cation transporter OCT\/SLC22A and H+\/organic cation antiporter MATE\/SLC47A are key molecules for nephrotoxicity of platinum agents. Biochem Pharmacol. 2011;81:563\u20138.","journal-title":"Biochem Pharmacol"},{"key":"390_CR13","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s10157-012-0620-8","volume":"16","author":"I Ito","year":"2012","unstructured":"Ito I, Ito Y, Mizuno M, et al. A rare case of acute kidney injury associated with autoimmune hemolytic anemia and thrombocytopenia after long-term usage of oxaliplatin. Clin Exp Nephrol. 2012;16:490\u20134.","journal-title":"Clin Exp Nephrol"},{"key":"390_CR14","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.2215\/CJN.01330213","volume":"8","author":"AK Muriithi","year":"2013","unstructured":"Muriithi AK, Nasr SH, Leung N. Utility of urine eosinophils in the diagnosis of acute interstitial nephritis. Clin J Am Soc Nephrol. 2013;8:1857\u201362.","journal-title":"Clin J Am Soc Nephrol"},{"key":"390_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3109\/08860229309065575","volume":"15","author":"M Koselj","year":"1993","unstructured":"Koselj M, Kveder R, Bren AF, et al. Acute renal failure in patients with drug-induced acute interstitial nephritis. Ren Fail. 1993;15:69\u201372.","journal-title":"Ren Fail"},{"issue":"8","key":"390_CR16","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/j.1398-9995.2004.00547.x","volume":"59","author":"WJ Pichler","year":"2004","unstructured":"Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy. 2004;59(8):809\u201320.","journal-title":"Allergy"},{"issue":"6","key":"390_CR17","doi-asserted-by":"publisher","first-page":"381","DOI":"10.5414\/CN108301","volume":"81","author":"MA Perazella","year":"2014","unstructured":"Perazella MA. Diagnosing drug-induced AIN in the hospitalized patient: a challenge for the clinician. Clin Nephrol. 2014;81(6):381\u20138.","journal-title":"Clin Nephrol"},{"key":"390_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000444026","volume":"43","author":"M Fiorentino","year":"2016","unstructured":"Fiorentino M, Bolignano D, Tesar V, et al. Renal biopsy in 2015\u2014from epidemiology to evidence-based indications. Am J Nephrol. 2016;43:1\u201319.","journal-title":"Am J Nephrol"},{"key":"390_CR19","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/ki.2010.89","volume":"77","author":"M Praga","year":"2010","unstructured":"Praga M, Gonz\u00e1lez E. Acute interstitial nephritis. Kidney Int. 2010;77:956\u201361.","journal-title":"Kidney Int"},{"key":"390_CR20","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1053\/j.ajkd.2014.04.027","volume":"64","author":"AK Muriithi","year":"2014","unstructured":"Muriithi AK, Leung N, Valeri AM, et al. Biopsy-proven acute interstitial nephritis 1993\u20132011: a case series. Am J Kidney Dis. 2014;64:558\u201366.","journal-title":"Am J Kidney Dis"},{"key":"390_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1309\/AJCPBVLJZH6W6RQM","volume":"136","author":"A Pierce","year":"2011","unstructured":"Pierce A, Nester T. Pathology consultation on drug-induced hemolytic anemia. Am J Clin Pathol. 2011;136:7\u201312.","journal-title":"Am J Clin Pathol"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-019-00390-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13730-019-00390-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-019-00390-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,29]],"date-time":"2020-02-29T19:21:48Z","timestamp":1583004108000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13730-019-00390-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,2]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["390"],"URL":"https:\/\/doi.org\/10.1007\/s13730-019-00390-8","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,2]]},"assertion":[{"value":"17 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Informed consent was obtained from the patient described in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}